| 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative D Aletaha, T Neogi, AJ Silman, J Funovits, DT Felson, CO Bingham III, ... Arthritis & rheumatism 62 (9), 2569-2581, 2010 | 14783 | 2010 |
| NF-κB: a key role in inflammatory diseases PP Tak, GS Firestein The Journal of clinical investigation 107 (1), 7-11, 2001 | 4913 | 2001 |
| Genetics of rheumatoid arthritis contributes to biology and drug discovery Y Okada, D Wu, G Trynka, T Raj, C Terao, K Ikari, Y Kochi, K Ohmura, ... Nature 506 (7488), 376-381, 2014 | 2479 | 2014 |
| Tumor necrosis factor antagonist mechanisms of action: a comprehensive review D Tracey, L Klareskog, EH Sasso, JG Salfeld, PP Tak Pharmacology & therapeutics 117 (2), 244-279, 2008 | 2123 | 2008 |
| Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci EA Stahl, S Raychaudhuri, EF Remmers, G Xie, S Eyre, BP Thomson, Y Li, ... Nature genetics 42 (6), 508-514, 2010 | 1571 | 2010 |
| Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis W Hueber, DD Patel, T Dryja, AM Wright, I Koroleva, G Bruin, C Antoni, ... Science translational medicine 2 (52), 52ra72-52ra72, 2010 | 1077 | 2010 |
| Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis FA Koopman, SS Chavan, S Miljko, S Grazio, S Sokolovic, PR Schuurman, ... Proceedings of the National Academy of Sciences 113 (29), 8284-8289, 2016 | 924 | 2016 |
| MicroRNA‐146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins Y Tang, X Luo, H Cui, X Ni, M Yuan, Y Guo, X Huang, H Zhou, N de Vries, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 912 | 2009 |
| 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of … A Ravelli, F Minoia, S Davì, AC Horne, F Bovis, A Pistorio, M Aricò, ... Arthritis & rheumatology 68 (3), 566-576, 2016 | 868 | 2016 |
| Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis GM Bartelds, CA Wijbrandts, MT Nurmohamed, S Stapel, WF Lems, ... Annals of the rheumatic diseases 66 (7), 921-926, 2007 | 728 | 2007 |
| Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity PP Tak, TJM Smeets, MR Daha, PM Kluin, KAE Meijers, R Brand, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1997 | 725 | 1997 |
| International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis J Braun, T Pham, J Sieper, J Davis, SJ Van der Linden, M Dougados, ... Annals of the rheumatic diseases 62 (9), 817-824, 2003 | 628 | 2003 |
| Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis GJ Wolbink, M Vis, W Lems, AE Voskuyl, E De Groot, MT Nurmohamed, ... Arthritis & Rheumatism 54 (3), 711-715, 2006 | 614 | 2006 |
| Common variants at CD40 and other loci confer risk of rheumatoid arthritis S Raychaudhuri, EF Remmers, AT Lee, R Hackett, C Guiducci, NP Burtt, ... Nature genetics 40 (10), 1216-1223, 2008 | 612 | 2008 |
| European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies L Gossec, JS Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, ... Annals of the rheumatic diseases 71 (1), 4-12, 2012 | 593 | 2012 |
| The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis PP Tak, B Bresnihan Arthritis & Rheumatism 43 (12), 2619-2633, 2000 | 559 | 2000 |
| Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis JJ Haringman, DM Gerlag, AH Zwinderman, TJM Smeets, MC Kraan, ... Annals of the rheumatic diseases 64 (6), 834-838, 2005 | 528 | 2005 |
| Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis MH Buch, JS Smolen, N Betteridge, FC Breedveld, G Burmester, T Dörner, ... Annals of the rheumatic diseases 70 (6), 909-920, 2011 | 520 | 2011 |
| Decrease in cellularity and expression of adhesion molecules by anti–tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis PP Tak, PC Taylor, FC Breedveld, TJM Smeets, MR Daha, PM Kluin, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1996 | 518 | 1996 |
| EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis DM Gerlag, K Raza, LGM Van Baarsen, E Brouwer, CD Buckley, ... Annals of the rheumatic diseases 71 (5), 638-641, 2012 | 512 | 2012 |
D GerlagCMO RxCelerate在 rxcelerate.com 的电子邮件经过验证
